J. Safra Sarasin Holding AG Raises Position in Humana Inc. $HUM

J. Safra Sarasin Holding AG raised its position in Humana Inc. (NYSE:HUM) by 41.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,773 shares of the insurance provider’s stock after buying an additional 1,389 shares during the period. J. Safra Sarasin Holding AG’s holdings in Humana were worth $827,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of HUM. Long Focus Capital Management LLC acquired a new position in Humana in the 3rd quarter valued at $34,212,000. Aberdeen Group plc boosted its stake in Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after purchasing an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares in the last quarter. Sustainable Insight Capital Management LLC grew its holdings in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after buying an additional 4,740 shares in the last quarter. Finally, Ninety One UK Ltd raised its position in shares of Humana by 57.2% in the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock valued at $28,815,000 after buying an additional 40,958 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on HUM shares. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $227.00 to $502.00 in a research note on Monday. Cantor Fitzgerald upped their price objective on shares of Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, July 7th. Truist Financial increased their price objective on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a report on Tuesday. Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Finally, TD Cowen boosted their target price on Humana from $211.00 to $350.00 and gave the stock a “hold” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, sixteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $325.87.

Humana Trading Up 0.2%

Shares of HUM stock opened at $406.70 on Wednesday. The company’s 50-day moving average price is $345.52 and its 200-day moving average price is $257.26. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock has a market cap of $48.83 billion, a price-to-earnings ratio of 43.50, a PEG ratio of 2.31 and a beta of 0.71. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $415.00.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period last year, the business earned $11.58 earnings per share. Humana’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts predict that Humana Inc. will post 9.03 earnings per share for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.